September 27, 2016 3:54 PM ET

Healthcare Providers and Services

Company Overview of Profarma Distribuidora de Produtos Farmacêuticos S.A.

Company Overview

Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Pharmaceutical Distribution, Specialties, and Retail divisions. It provides medicines, personal care, health and beauty care, oncological, and dermatological products; and toiletries, vaccines, prostheses, and hormones in the South, Southeast, Northeast, and Center-West regions of Brazil through 11 distribution centers. The company also operates approximately 123 stores in the state of Rio de Janeiro. In addition, it provides information technology, cargo and transportation planning a...

Avenida das Américas, 500

bloco 12

sala 106

Rio de Janeiro, RJ 22640-100

Brazil

Founded in 1961

5,570 Employees

Phone:

55 21 4009 0200

Key Executives for Profarma Distribuidora de Produtos Farmacêuticos S.A.

Profarma Distribuidora de Produtos Farmacêuticos S.A. does not have any Key Executives recorded.

Profarma Distribuidora de Produtos Farmacêuticos S.A. Key Developments

Brasil Pharma Reportedly Nears Sale Of Big Ben And Rosário

Brasil Pharma S.A. (BOVESPA:BPHA3) is close to selling two units for approximately BRL 1.2 billion. Profarma Distribuidora de Produtos Farmacêuticos S.A. (BOVESPA:PFRM3) is said to be nearing a BRL 200 million deal to acquire Drogaria Rosário Distrital from Brasil Pharma in coming days while Ultrapar Participações S.A. (BOVESPA:UGPA3) is said to be nearing a deal worth BRL 1 billion to acquire Distribuidora Big Ben S.A. from Brasil Pharma, according to sources.

Profarma Reports Earnings Results for the Second Quarter Ended June 30, 2016

Profarma reported earnings results for the second quarter ended June 30, 2016. For the quarter, the company reported 15.2% revenue growth to BRL 1.4 billion and revenues from the pharma distribution division totaled BRL 1 billion, an 11.4% increase over the second quarter of 2015. Earnings before interest, taxes, depreciation, and amortisation (EBITDA) were BRL 54.1 million, up 99%. In the specialities division, sales grew 41.9% during the second quarter to BRL 246.5 million, driven by a 54.2% increase in sales to the private sector.

Profarma Distribuidora De Produtos Farmacêuticos S.A. Announces Consolidated and Parent Earnings Results for the First Quarter Ended March 31, 2016

Profarma Distribuidora de Produtos Farmacêuticos S.A. announced consolidated earnings results for the first quarter ended March 31, 2016. For the quarter, the consolidated company reported net operating revenue of BRL 978,056,000 compared with BRL 823,707,000 for the same period a year ago. Operating loss was BRL 10,545,000 compared with BRL 9,918,000 for the same period a year ago. Net loss before Minority Interests and net loss was BRL 9,251,000 compared with BRL 7,636,000 for the same period a year ago. Cash used in operating activities was BRL 40,782,000 compared with cash provided by operating activities of BRL 32,893,000 for the same period a year ago. Additions to fixed assets was BRL 3,471,000 compared with BRL 8,642,000 for the same period a year ago. Additions to intangible assets was BRL 497,000 compared with BRL 208,000 for the same period a year ago. Net debt was BRL 287.7 million compared with BRL 205.1 million for the same period a year ago. Ebitda was BRL 20.7 million compared with BRL 13.5 million for the same period a year ago. For the quarter, the parent company reported net operating revenue of BRL 896,313,000 compared with BRL 788,945,000 for the same period a year ago. Operating loss was BRL 11,311,000 compared with BRL 9,811,000 for the same period a year ago. Net loss before Minority Interests and net loss was BRL 9,251,000 compared with BRL 7,636,000 for the same period a year ago. Cash used in operating activities was BRL 39,901,000 compared with cash provided by operating activities of BRL 37,654,000 for the same period a year ago. Additions to fixed assets was BRL 2,544,000 compared with BRL 5,656,000 for the same period a year ago.

Similar Private Companies By Industry

Company Name Region
4-Bio Medicamentos Ltda. Americas
Agemed Saúde S/A Americas
Aite Gestao em Saude Ltda. Americas
Alliar Medicina Diagnóstica Americas
Almapal S.A. Americas

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
November 16, 2015
Itamaraty Empreendimentos e Participações S/A
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Profarma Distribuidora de Produtos Farmacêuticos S.A., please visit www.profarma.com.br. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.